Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Change in Cash (2020 - 2025)

Roivant Sciences' Change in Cash history spans 6 years, with the latest figure at $241.6 million for Q4 2025.

  • For Q4 2025, Change in Cash rose 105.31% year-over-year to $241.6 million; the TTM value through Dec 2025 reached -$5.8 billion, down 41.91%, while the annual FY2025 figure was -$3.8 billion, 178.73% down from the prior year.
  • Change in Cash reached $241.6 million in Q4 2025 per ROIV's latest filing, up from -$1.4 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $5.0 billion in Q4 2023 to a low of -$4.5 billion in Q4 2024.
  • Average Change in Cash over 5 years is -$408.4 million, with a median of -$133.3 million recorded in 2021.
  • Peak YoY movement for Change in Cash: surged 1036.84% in 2023, then crashed 13748.95% in 2024.
  • A 5-year view of Change in Cash shows it stood at $84.5 million in 2021, then crashed by 731.07% to -$533.0 million in 2022, then soared by 1036.84% to $5.0 billion in 2023, then tumbled by 191.1% to -$4.5 billion in 2024, then surged by 105.31% to $241.6 million in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Change in Cash are $241.6 million (Q4 2025), -$1.4 million (Q3 2025), and -$1.5 billion (Q2 2025).